BHCM
RXST icon

Brevan Howard Capital Management’s RxSight RXST Stock Holding History

Brevan Howard Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.1K Sell
11,374
-18,119
-61% -$150K ﹤0.01% 2062
2025
Q4 		$307K Buy
29,493
+7,877
+36% +$79K ﹤0.01% 1363
2025
Q3 		$194K Buy
21,616
+8,459
+64% +$74.2K ﹤0.01% 1762
2025
Q2 		$171K Buy
+13,157
New +$198K ﹤0.01% 1739

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Brevan Howard Capital Management's RXST Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its RxSight (RXST) stake by 61% in Q1 2026, selling an estimated $150K and leaving 11,374 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

Brevan Howard Capital Management first reported a position in RXST in Q2 2025 and has held it in 4 quarters since. The position peaked at $307K in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Brevan Howard Capital Management held 11,374 shares of RxSight worth $70.1K as of Q1 2026.
  • Brevan Howard Capital Management sold 18,119 RxSight shares in Q1 2026, an estimated $150K.
  • RxSight made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #2062 holding.
  • Brevan Howard Capital Management first reported a position in RxSight in Q2 2025 and has held it in 4 quarters since.
  • Brevan Howard Capital Management's RxSight position peaked at $307K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.